This disclosure relates to new azepino[4,5-b]indole compounds that may be
used to modulate a histamine receptor in an individual. Novel compounds
are described, including new 1,2,3,4,5,6-tetrahydroazepino[4,5-b]indoles.
Pharmaceutical compositions are also provided.